Atea Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Atea Pharmaceuticals, Inc.‘s stocks are currently a part of 106 hedge funds’ portfolios, which represents 64.69% of the total amount of its stocks outstanding. This makes up a total of 53.86M shares of Atea Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -6.42% or -3.69M shares fewer. As for the holding position changes, 44.34% (47) of current hedge fund investors increased the number of shares held, 25.47% (27) of current holders sold a part of the shares held, and 15.09% (16) closed the holdings completely. 12 hedge funds are new holders of Atea Pharmaceuticals, Inc. stock in Q3 2022, it is 11.32% of total holders.
Hedge funds holding Atea Pharmaceuticals (Q1 2016 – Q3 2022)
| Q1 2016 | 2 |
|---|---|
| Q2 2016 | 43 |
| Q3 2016 | 41 |
| Q4 2016 | 40 |
| Q1 2017 | 30 |
| Q2 2017 | 27 |
| Q3 2017 | 28 |
| Q4 2017 | 27 |
| Q1 2018 | 0 |
| Q4 2020 | 68 |
| Q1 2021 | 79 |
| Q2 2021 | 101 |
| Q3 2021 | 137 |
| Q4 2021 | 134 |
| Q1 2022 | 121 |
| Q2 2022 | 123 |
| Q3 2022 | 106 |
Hedge funds changes in Atea Pharmaceuticals positions (Q1 2016 – Q3 2022)
| Q1 2016 | 2 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2016 | 42 | 0 | 0 | 1 | 0 |
| Q3 2016 | 2 | 11 | 13 | 4 | 11 |
| Q4 2016 | 8 | 8 | 10 | 9 | 5 |
| Q1 2017 | 4 | 13 | 5 | 10 | -2 |
| Q2 2017 | 5 | 4 | 6 | 8 | 4 |
| Q3 2017 | 4 | 7 | 2 | 2 | 13 |
| Q4 2017 | 5 | 7 | 6 | 6 | 3 |
| Q1 2018 | 0 | 0 | 0 | 27 | -27 |
| Q4 2020 | 68 | 0 | 0 | 0 | 0 |
| Q1 2021 | 18 | 24 | 24 | 7 | 6 |
| Q2 2021 | 39 | 41 | 17 | 17 | -13 |
| Q3 2021 | 54 | 41 | 30 | 17 | -5 |
| Q4 2021 | 45 | 44 | 33 | 48 | -36 |
| Q1 2022 | 21 | 36 | 43 | 32 | -11 |
| Q2 2022 | 21 | 38 | 41 | 15 | 8 |
| Q3 2022 | 12 | 47 | 27 | 16 | 4 |
Hedge funds changes in Atea Pharmaceuticals stock options (Q1 2016 – Q3 2022)
| Q1 2016 | 0 | 0 |
|---|---|---|
| Q2 2016 | 0 | 4,000 |
| Q3 2016 | 0 | 0 |
| Q4 2016 | 0 | 0 |
| Q1 2017 | 0 | 0 |
| Q2 2017 | 0 | 0 |
| Q3 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 2,043,000 | 1,118,000 |
| Q2 2021 | 3,754,000 | 4,770,000 |
| Q3 2021 | 13,016,000 | 11,783,000 |
| Q4 2021 | 15,804,000 | 14,245,000 |
| Q1 2022 | 4,063,000 | 5,473,000 |
| Q2 2022 | 13,972,000 | 935,000 |
| Q3 2022 | 12,311,000 | 540,000 |